Publications in collaboration with researchers from University Medical Center Freiburg (22)

2023

  1. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    The European respiratory journal, Vol. 61, Núm. 1

  2. Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial

    The Lancet Respiratory Medicine, Vol. 11, Núm. 1, pp. 74-86

  3. Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in rome November 2022

    Clinical Nutrition

2022

  1. Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial

    The Lancet Haematology, Vol. 9, Núm. 1, pp. e14-e25

2021

  1. ESPEN practical guideline: Clinical nutrition in chronic intestinal failure

    Clinical Nutrition, Vol. 40, Núm. 9, pp. 5196-5220

  2. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

    Leukemia, Vol. 35, Núm. 3, pp. 835-849

  3. Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2844-2852.e5

2020

  1. Characteristics and treatment regimens across ERS SHARP severe asthma registries

    European Respiratory Journal, Vol. 55, Núm. 1

  2. EAACI-Leitlinien zur allergen-spezifischen Immuntherapie: Insektengiftallergie

    Allergologie, Vol. 43, Núm. 5, pp. 176-203

  3. Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts

    Radiotherapy and Oncology, Vol. 149, pp. 84-88

2019

  1. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

    Journal of Clinical Medicine, Vol. 8, Núm. 11

  2. Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts

    Radiotherapy and Oncology, Vol. 133, pp. 163-166

2018

  1. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia

    Annals of Neurology, Vol. 84, Núm. 5, pp. 729-740

2016

  1. Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: Application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 3, pp. 794-802

2015

  1. Normal reference values of left ventricular strain using three-dimensional speckle tracking echocardiography: Results from amulticentre study

    European Heart Journal Cardiovascular Imaging, Vol. 16, Núm. 4, pp. 410-416

2014

  1. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: Prevalence and survival - An analysis of data from the ERA-EDTA Registry

    Nephrology Dialysis Transplantation, Vol. 29, pp. iv15-iv25

2011

  1. Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: The SEISMIC trial

    EuroIntervention, Vol. 6, Núm. 7, pp. 805-812

  2. Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study

    The Lancet Oncology, Vol. 12, Núm. 8, pp. 795-805

2009

  1. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration

    Transplantation, Vol. 88, Núm. 9, pp. 1101-1108

  2. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial

    JACC: Cardiovascular Interventions, Vol. 2, Núm. 11, pp. 1083-1091